TrialPanorama/TrialPanorama-database huggingface dataset:
Study 26030696 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 26030696 — Predictive Biomarker (PRD): SERPINA10 mRNA
Genes: SERPINA10; ZPI; UNQ707/PRO1358
Study 26030696 — Predictive Biomarker (PRD): DLC1 mRNA
Genes: DLC1; ARHGAP7; KIAA1723; STARD12
Study 26037515 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 26038121 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 26038121 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study 26038121 — Predictive Biomarker (PRD): NRIP1 mRNA
Genes: NRIP1
Study 26038121 — Predictive Biomarker (PRD): SEPTIN10 mRNA
Genes: SEPTIN10; SEPT10
Study 26038121 — Predictive Biomarker (PRD): ZNF667 mRNA
Genes: ZNF667
Study 26038121 — Predictive Biomarker (PRD): TGFBR3 mRNA
Genes: TGFBR3
Study 26038121 — Predictive Biomarker (PRD): MBOAT1 mRNA
Genes: MBOAT1; OACT1
Study 26038121 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 26038121 — Predictive Biomarker (PRD): CRY1 mRNA
Genes: CRY1; PHLL1
Study 26038537 — Predictive Biomarker (PRD): RAPGEF5 mRNA
Genes: RAPGEF5; GFR; KIAA0277; MRGEF
Study 26038709 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 26040806 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 26041651 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 26041763 — Predictive Biomarker (PRD): JUN mRNA
Genes: JUN
Study 26045135 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 26048034 — Predictive Biomarker (PRD): MAN2B1 mRNA
Genes: MAN2B1; LAMAN; MANB
Study 26048404 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 26048877 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 26049121 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 26049121 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 26049121 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26049686 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 26049686 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 26049896 — Predictive Biomarker (PRD): SMPD1 mRNA
Genes: SMPD1; ASM
Study 26053664 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 26056248 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study 26058927 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 26059242 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26059647 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26059647 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 26059948 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 26060319 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 26060319 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26062823 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 26062823 — Predictive Biomarker (PRD): ALK
Genes: CD246; ALK1
Study 26062823 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 26063633 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study 26063633 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26063893 — Surrogate Endpoint (SUR): Pathological complete response
Study 26064113 — Surrogate Endpoint (SUR): Blood pressure
Study 26064192 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 26065651 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 26065651 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 26066077 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 26066744 — Surrogate Endpoint (SUR): Blood pressure
Study 26068543 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study 26068543 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 26069234 — Predictive Biomarker (PRD): FABP4 mRNA
Genes: FABP4
Study 26069305 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 26070531 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26070683 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 26070683 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26071053 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study 26071053 — Predictive Biomarker (PRD): FOXP1 mRNA
Genes: FOXP1; HSPC215
Study 26071053 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 26071053 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 26071091 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 26071133 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26071133 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26071868 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 26072403 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study 26073352 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 26073451 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 26075081 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study 26075496 — Predictive Biomarker (PRD): TNXB mRNA
Genes: TNXB; HXBL; TNX; TNXB1; TNXB2; XB
Study 26075496 — Predictive Biomarker (PRD): CYP21A2 mRNA
Genes: CYP21A2; CYP21; CYP21B
Study 26077240 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 26077240 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 26077415 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26081121 — Surrogate Endpoint (SUR): Blood pressure
Study 26081793 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 26082815 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 26083135 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 26083256 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26083256 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26083430 — Predictive Biomarker (PRD): MMP7 mRNA
Genes: MMP7; MPSL1; PUMP1
Study 26084515 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 26084896 — Surrogate Endpoint (SUR): Blood pressure
Study 26084989 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study 26084990 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26085490 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 26088933 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 26089177 — Surrogate Endpoint (SUR): Blood pressure
Study 26089212 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 26093811 — Surrogate Endpoint (SUR): Serum calcium
Study 26093865 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26093876 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26093923 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26093923 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 26094738 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study 26095067 — Predictive Biomarker (PRD): LTB mRNA
Genes: LTB; TNFC; TNFSF3
Study 26095067 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26095669 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study 26095669 — Predictive Biomarker (PRD): CCR7 mRNA
Genes: CCR7; CMKBR7; EBI1; EVI1
Study 26095669 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26095669 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 26095785 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 26098215 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study 26098215 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 26098215 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 26098215 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study 26098748 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 26098748 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 26099302 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 26105149 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 26106964 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 26108094 — Surrogate Endpoint (SUR): Bone mineral density
Study 26109496 — Surrogate Endpoint (SUR): Bone mineral density
Study 26109816 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 26109878 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 26111297 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 26111297 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study 26111297 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 26115532 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 26116238 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26116238 — Surrogate Endpoint (SUR): Pathological complete response
Study 26116658 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 26116658 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 26119560 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26121490 — Predictive Biomarker (PRD): FCMR mRNA
Genes: FCMR; FAIM3; TOSO
Study 26121490 — Predictive Biomarker (PRD): PLAC8 mRNA
Genes: PLAC8; BM-004
Study 26123189 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 26123926 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 26126206 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 26126206 — Safety Biomarker (SAF): Cytochrome c
Study 26132091 — Safety Biomarker (SAF): Reactive oxygen species
Study 26132314 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 26135770 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 26136476 — Safety Biomarker (SAF): HLA-DQB1
Genes: IDDM1; CELIAC1
Study 26137304 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26137953 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26137953 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26137961 — Predictive Biomarker (PRD): CD200 mRNA
Genes: CD200; MOX1; MOX2; My033
Study 26137961 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study 26137961 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 26137961 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 26138630 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26138630 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 26138702 — Surrogate Endpoint (SUR): Blood pressure
Study 26139558 — Surrogate Endpoint (SUR): Blood pressure
Study 26143264 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 26143264 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 26143264 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 26146564 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26148750 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26153272 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26153272 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 26155776 — Predictive Biomarker (PRD): PROCR mRNA
Genes: PROCR; EPCR
Study 26155776 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 26155776 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 26155941 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 26155957 — Surrogate Endpoint (SUR): Blood pressure
Study 26155994 — Surrogate Endpoint (SUR): Blood pressure
Study 26156741 — Predictive Biomarker (PRD): PLA2G10 mRNA
Genes: PLA2G10
Study 26156741 — Predictive Biomarker (PRD): FAR1 mRNA
Genes: FAR1; MLSTD2; UNQ2423/PRO4981
Study 26161450 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26169270 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 26169270 — Pharmacodynamic Biomarker (PDY): T-lymphocyte activation antigen CD86
Genes: CD86; CD28LG2
Study 26169613 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study 26169613 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study 26169613 — Predictive Biomarker (PRD): Protein patched homolog 1
Genes: PTCH1; PTCH
Study 26169613 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 26169615 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 26169889 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 26170650 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 26170650 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26171795 — Predictive Biomarker (PRD): PLIN3 mRNA
Genes: PLIN3; M6PRBP1; TIP47
Study 26172205 — Predictive Biomarker (PRD): CSRP3 mRNA
Genes: CSRP3; CLP; MLP
Study 26173796 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26176325 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study 26176325 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 26176325 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 26176329 — Predictive Biomarker (PRD): SH2D1A mRNA
Genes: SH2D1A; DSHP; SAP
Study 26177212 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 26177212 — Predictive Biomarker (PRD): NOD2 mRNA
Genes: NOD2; CARD15; IBD1
Study 26177495 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 26177495 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 26177495 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26177495 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26177495 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26178412 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26178526 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 26178526 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 26178526 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 26178526 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 26178526 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26179200 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 26179200 — Predictive Biomarker (PRD): CSF1 mRNA
Genes: CSF1
Study 26180085 — Predictive Biomarker (PRD): MAP3K5 mRNA
Genes: MAP3K5; ASK1; MAPKKK5; MEKK5
Study 26180085 — Predictive Biomarker (PRD): DBF4 mRNA
Genes: DBF4; ASK; DBF4A; ZDBF1
Study 26181029 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26181029 — Predictive Biomarker (PRD): MAPK1 mRNA
Genes: MAPK1; ERK2; PRKM1; PRKM2
Study 26181354 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 26182309 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 26182309 — Predictive Biomarker (PRD): PLCG2 mRNA
Genes: PLCG2
Study 26183044 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 26183044 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26183076 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study 26184520 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 26184520 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 26184520 — Predictive Biomarker (PRD): TIE1 mRNA
Genes: TIE1; TIE
Study 26184520 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 26185466 — Predictive Biomarker (PRD): MSN mRNA
Genes: MSN
Study 26185773 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 26186012 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26186299 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study 26186299 — Predictive Biomarker (PRD): GNAS mRNA
Genes: GNAS; GNAS1
Study 26186299 — Predictive Biomarker (PRD): FGFR4 mRNA
Genes: FGFR4; JTK2; TKF
Study 26186432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26186432 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26186440 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26186440 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 26186440 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26186440 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26187290 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 26187751 — Surrogate Endpoint (SUR): Pathological complete response
Study 26187864 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 26187864 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 26188235 — Predictive Biomarker (PRD): GNAS mRNA
Genes: GNAS; GNAS1
Study 26190488 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study 26190488 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 26190488 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26190562 — Surrogate Endpoint (SUR): Serum uric acid
Study 26193343 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 26193343 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study 26195015 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26195015 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 26195220 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 26195720 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 26195720 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 26196233 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 26198286 — Surrogate Endpoint (SUR): Serum creatinine
Study 26199039 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 26199392 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 26199392 — Surrogate Endpoint (SUR): Serum creatinine
Study 26199453 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 26199453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26199453 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26201460 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 26201817 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study 26202132 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26205955 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 26208006 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study 26208483 — Predictive Biomarker (PRD): Hormone receptor
Study 26208671 — Surrogate Endpoint (SUR): Blood pressure
Study 26209332 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study 26209332 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 26210388 — Surrogate Endpoint (SUR): Blood pressure
Study 26210388 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26210682 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 26210682 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 26211987 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 26213309 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26213798 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 26216294 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 26216294 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study 26216360 — Surrogate Endpoint (SUR): Forced vital capacity
Study 26216692 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 26217225 — Surrogate Endpoint (SUR): Blood pressure
Study 26217542 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 26217542 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 26221665 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 26222558 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 26222558 — Predictive Biomarker (PRD): CSF1 mRNA
Genes: CSF1
Study 26222884 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study 26223768 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A